Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic
Hazell et al., BMJ Open, doi:10.1136/bmjopen-2025-100583
https://c19early.org/hazell.html